Bonus: a lightning round of which titles could be coming back. Never say never on more 'Mask' and 'Snakes on a Plane' but don ...
Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.
A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...
Intellia Therapeutics (NTLA) announced the first patient has been dosed in MAGNITUDE-2, a global, pivotal Phase 3 trial of nexiguran ...
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results